Butterfly Network (BFLY) Liabilities and Shareholders Equity (2020 - 2026)
Butterfly Network's (BFLY) quarterly Liabilities and Shareholders Equity came in at $283.0 million in Q2 2026, down 9.67% year-over-year from $313.3 million in Q2 2025, and down 1.02% quarter-over-quarter from $285.9 million in Q1 2026.
Analysis
Butterfly Network (BFLY) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
Butterfly Network has disclosed Liabilities and Shareholders Equity across 7 years of filings, most recently posting $283.0 million for Q2 2026.
- In Q2 2026, Liabilities and Shareholders Equity fell 9.67% year-over-year to $283.0 million; the TTM figure through Jun 2026 stood at $1.2 billion (changed 0.21% YoY), while the FY2025 annual figure was $296.5 million, up 15.8% from the prior year.
- Liabilities and Shareholders Equity came in at $283.0 million for Q2 2026 at Butterfly Network, down from $285.9 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $535.4 million in Q1 2022 to a low of $256.1 million in Q4 2024.
- Average Liabilities and Shareholders Equity over 5 years is $341.3 million, with a median of $308.8 million recorded in 2023.
- Year-over-year, Liabilities and Shareholders Equity declined 28.71% in 2023 and gained 15.8% in 2025.
- Over 5 years, Liabilities and Shareholders Equity stood at $417.6 million in 2022, then decreased by 27.13% to $304.3 million in 2023, then dropped by 15.84% to $256.1 million in 2024, then advanced by 15.8% to $296.5 million in 2025, then decreased by 4.57% to $283.0 million in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $283.0 million in Q2 2026, $285.9 million in Q1 2026, and $296.5 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | 37.25 Bn |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | 2.41 Bn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | 344.46 Mn |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | 3.35 Bn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | 283.00 Mn |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | 5.72 Bn |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | 166.35 Mn |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | 30.24 Mn |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 1.10 Bn |
| 10 | Prenetics Global | 357.49 Mn | 298.35 Mn | 30.20 Mn | 153.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 283.00 Mn |
| Mar 31, 2026 | 285.92 Mn |
| Dec 31, 2025 | 296.53 Mn |
| Sep 30, 2025 | 290.00 Mn |
| Jun 30, 2025 | 313.28 Mn |
| Mar 31, 2025 | 318.41 Mn |
| Dec 31, 2024 | 256.08 Mn |
| Sep 30, 2024 | 265.27 Mn |
| Jun 30, 2024 | 273.07 Mn |
| Mar 31, 2024 | 284.29 Mn |
| Dec 31, 2023 | 304.27 Mn |
| Sep 30, 2023 | 334.22 Mn |
| Jun 30, 2023 | 364.59 Mn |
| Mar 31, 2023 | 381.68 Mn |
| Dec 31, 2022 | 417.57 Mn |
| Sep 30, 2022 | 443.26 Mn |
| Jun 30, 2022 | 496.64 Mn |
| Mar 31, 2022 | 535.42 Mn |
| Dec 31, 2021 | 571.97 Mn |
| Sep 30, 2021 | 580.32 Mn |